PCV30 CLOPIDOGREL IS COST-EFFECTIVE COMPARED WITH ASPIRIN IN UNITED KINGDOM PATIENTS WITH A MYOCARDIAL INFARCTION WHO SUBSEQUENTLY SUSTAIN AN ISCHAEMIC STROKE OR PERIPHERAL ARTERIAL DISEASE EVENT

May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70618-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)70618-5/fulltext
Section Title :
Section Order : 347
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70618-5&doi=10.1016/S1098-3015(10)70618-5
HEOR Topics :
Tags :
Regions :